BACKGROUND Lesions of the lacrimal fossa and gland constitute about 5%-13% of all orbital masses confirmed by biopsy. The diagnosis, the histopathological correlation and treatment of lacrimal fossa lesions are important to ophthalmologists. The aim of this study is to analyse retrospectively 31 cases of lacrimal fossa lesions diagnosed over a 10-year period. MATERIALS AND METHODS The clinical features and the histopathological features of 31 cases diagnosed as lacrimal fossa lesions between 2004 September and 2014 August were retrospectively analysed from case records in a tertiary care centre at
AIM:To compare the efficacy of 0.1% Fluoromethalone eye drops versus supratarsal injection of Triamcinolone acetonide (20mg) in the treatment of palpebral type of vernal kerato conjunctivitis. SETTINGS AND DESIGN: Prospective study. MATERIALS AND METHODS: 60 patients with palpebral type of vernal kerato conjunctivitis were divided into 2 groups of 30 each. After an informed and written consent, 30 patients were treated with 0.1% Fluorometholone eye drops & 30 were treated with supratarsal injection of 0.5ml of Triamcinolone (20mg). All treated patients were followed up for a period of 4 weeks. Results were analysed with respect to symptoms and signs of improvement. RESULTS: Patients who were given supratarsal injection of Triamcinolone (20mg) showed effective therapeutic response in 1 to 2 weeks and patients who were given 0.1% Fluorometholone eye drops showed in 4 to 5 weeks. Patients with Triamcinolone showed higher rate of improvement of clinical response and low recurrence rate. CONCLUSION: Supratarsal injection of Triamcinolone (20mg) is an effective and safe method of treatment of refractory and severe cases of VKC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.